A pilot phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung Meeting Abstract
| Authors: | Haura, E. B.; Larson, T. G.; Stella, P. J.; Bazhenova, L.; Miller, V. A.; Cohen, R. B.; Eisenberg, P. D.; Selaru, P.; Wilner, K. D.; Ricart, A. D.; Gadgeel, S. M. |
| Abstract Title: | A pilot phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung |
| Meeting Title: | AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics |
| Journal Title: | Molecular Cancer Therapeutics |
| Volume: | 6 |
| Issue: | 12 |
| Meeting Dates: | 2007 Oct 22-26 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 1535-7163 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2007-12-01 |
| Start Page: | 3468S |
| End Page: | 3469S |
| Language: | English |
| ACCESSION: | WOS:000251969000409 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: B110 - Poster Presentation - Part 2 - "Source: Wos" |
MSK Authors
-
270Miller